RITA BELOBROV: Open Payments
NPI 1588006209 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,971 in 141 payments from 23 companies in 2025. Trend: 2023 $863 · 2024 $1,489 · 2025 $2,971
Food & beverage: $2,782Education: $189
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $770 |
| Janssen Biotech, Inc. | 20 | $716 |
| PFIZER INC. | 15 | $263 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $176 |
| Madrigal Pharmaceuticals | 11 | $172 |
| Phathom Pharmaceuticals, Inc. | 3 | $154 |
| Aimmune Therapeutics, Inc. | 5 | $93 |
| Ferring Pharmaceuticals Inc. | 4 | $91 |
| Regeneron Healthcare Solutions, Inc. | 4 | $75 |
| Ardelyx, Inc. | 3 | $64 |
Products named: TREMFYA, RINVOQ, SKYRIZI, VELSIPITY, REZDIFFRA, VOQUEZNA, ENTYVIO, DUPIXENT.
Industry payments across NJ — which companies pay providers there.
